|Articles|April 1, 1996

April 1996
Volume 2
Issue 4

Ethics in Managed Care: The Obligation of Administration to Attending to Consequences

Author(s)Nancy Neveloff Dubler, LLB

Download PDF: Ethics in Managed Care: The Obligation of Administration to Attending to Consequences

Articles in this issue

almost 30 years ago

Article

Implementing Guidelines for Eye Care of Diabetic Patients: Results from an HMO Intervention Study

almost 30 years ago

Article

Diagnosis and Eradication of Helicobacter pylori in the Management of Peptic Ulcer Disease: A Decision Analysis Model

almost 30 years ago

Article

Improved Outcomes of an Outpatient Pediatric Asthma Patient Management Program in an IPA HMO

almost 30 years ago

Article

Alternatives to Abdominal Hysterectomy: A Review of Clinical and Economic Outcomes

almost 30 years ago

Article

Outcomes and Costs of Care for Acute Low Back Pain Among Specialties: Implications for Managed Care

almost 30 years ago

Article

Accounting Changes Can Affect Healthcare Delivery: The Issuance of FASB Statements of Financial Accounting Standards 81 and 106

almost 30 years ago

Article

Cost-Effective Hypertension Management: Comparison of Drug Therapies with an Alternative Program

almost 30 years ago

Article

Improved Screening for Diabetic Eye Disease: How a Managed Care Plan Helped

almost 30 years ago

Article

"When They Give You the Money, You've Won" Drug Makers Settle Discriminatory Pricing Suit. Or Do They?

almost 30 years ago

Article

Cost-Effectiveness and Complementary Medicine

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Ethics in Managed Care: The Obligation of Administration to Attending to Consequences

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

5 Things to Know About the Oral GLP-1 Era